Tapering gradually under the guidance of your prescriber is the safest way to stop taking Wellbutrin (bupropion), and for most people it means stepping the dose down over several weeks rather than quitting all at once. Bupropion has a different pharmacological profile from most other antidepressants, which changes the withdrawal picture in ways that are worth understanding before you begin. The process is manageable for the majority of people, but it does involve real decisions about timing, dose reductions, and how to handle symptoms if they appear.
Why Bupropion Is Different From Most Antidepressants
Most commonly prescribed antidepressants work primarily on serotonin. Bupropion does not. It acts by inhibiting the reuptake of norepinephrine and dopamine, with no clinically significant effect on the serotonin system.1PubMed Central. A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor This distinction matters when you stop taking it, because the withdrawal symptoms most people associate with antidepressants, such as brain zaps, electric-shock sensations, and severe dizziness, are driven largely by serotonin disruption. Bupropion users tend to experience a milder discontinuation profile.
That said, “milder” does not mean “nonexistent.” Bupropion and its metabolites have a wide range of half-lives, roughly 7 to 46 hours depending on the specific metabolite, and some of those metabolites are pharmacologically active.2The Journal of Pharmacology and Experimental Therapeutics. Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers This means that when you stop taking bupropion, the drug and its active byproducts clear your system at different rates. The result can be an uneven adjustment period, even if the overall withdrawal is less intense than what happens with serotonin-based antidepressants.
What Discontinuation Symptoms Can Look Like
A large systematic review and meta-analysis of antidepressant discontinuation found that stopping antidepressants was associated with increased odds of dizziness, nausea, vertigo, and nervousness compared to people who stopped a placebo.3JAMA Network. Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis Dizziness was the single most common symptom. Those findings draw from antidepressants as a class, including serotonergic drugs that tend to produce more pronounced withdrawal than bupropion. Still, they sketch the general landscape of what can happen when your brain adjusts to the absence of a medication it has adapted to.
People stopping bupropion commonly report irritability, mood swings, fatigue, trouble concentrating, and sleep disruption. Some notice flu-like symptoms such as body aches or headaches. The intensity of these symptoms varies widely depending on how long you have been taking the drug, what dose you are on, and your individual metabolism. A broad review of psychotropic medication withdrawal found that all classes of these drugs can induce withdrawal syndromes, even with slow tapering.4Karger Publishers (Psychotherapy and Psychosomatics). Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications The fact that withdrawal can occur even when tapering is done carefully is an important point to set expectations around: a well-planned taper reduces the severity and duration of symptoms, but it may not eliminate them entirely.
How to Tell Withdrawal From a Return of Depression
One of the trickiest parts of coming off any antidepressant is figuring out whether the way you feel is a temporary withdrawal effect or the beginning of a relapse into depression. The two can look similar on the surface, especially in the first few weeks. Research helps draw a practical line between them.
A study tracking people who discontinued antidepressants found that withdrawal symptoms peaked earlier than depressive symptoms. Withdrawal scores peaked at roughly day 22 after stopping, while depression scores peaked around day 28.5PubMed Central. Do withdrawal symptoms predict depression relapse after antidepressant cessation? About one in five people in the discontinuation group reported at least one symptom that occurred only in people stopping the drug and not in those who continued it, symptoms that may help clinicians distinguish withdrawal from relapse. The practical takeaway is that withdrawal symptoms tend to show up quickly and start fading within a few weeks. If low mood, loss of interest, and other core depression symptoms keep building or persist beyond a month, that is more likely to be a relapse than a withdrawal effect.
The same meta-analysis mentioned earlier found that discontinuation was not associated with an increase in depression symptoms, despite the study populations being people with major depressive disorder.3JAMA Network. Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis This is reassuring: the physical discomfort of stopping does not automatically mean your depression is returning. However, it also does not mean relapse cannot happen. Having a plan with your prescriber for what to do if symptoms persist beyond the typical withdrawal window is worth setting up before you begin tapering.
What a Practical Taper Usually Looks Like
There is no single tapering schedule that works for everyone, and guidelines vary by prescriber. The general principle, though, is straightforward: reduce your dose in steps over weeks rather than stopping suddenly. For someone on 300 mg of the extended-release formulation, a common approach is to drop to 150 mg for two to four weeks, then stop. Some prescribers prefer even smaller steps, particularly if you have been on the medication for a long time or have a history of sensitivity to medication changes.
Bupropion is available in immediate-release, sustained-release, and extended-release formulations, and the formulation matters during a taper. Extended-release tablets should not be cut or crushed because doing so disrupts the mechanism that controls how the drug enters your system and can increase the risk of seizures, which is a known dose-dependent risk with bupropion. If the available tablet sizes do not allow the step you need, your prescriber may switch you to a different formulation or prescribe a compounded dose. Do not improvise your own dose reduction by splitting extended-release pills.
The research on serotonergic antidepressants shows that the relationship between dose and receptor occupancy is not linear: small reductions at higher doses make relatively little difference, while the same absolute reduction at a low dose produces a much larger change in brain chemistry.6Molecular Psychiatry. The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review This finding underpins the “hyperbolic tapering” approach now recommended for SSRIs and SNRIs, where dose cuts get proportionally smaller as you go lower. Bupropion’s mechanism is different since it does not act on serotonin transporters, so the same receptor-occupancy curve may not directly apply. Still, the broad principle of making the final dose reductions smaller and slower is considered good clinical practice for any antidepressant taper.
Working With Your Prescriber on the Plan
Research on shared decision-making around antidepressant discontinuation consistently finds that both patients and clinicians rank the same five concerns as most important: having an individualized dose-reduction schedule, planning for relapse prevention, addressing fear of relapse, receiving clear information about withdrawal symptoms, and drawing on previous experiences with dose changes.7British Journal of General Practice. Enhancing shared decision making about discontinuation of antidepressant medication: a concept-mapping study in primary and secondary mental health care Where patients and professionals diverged was on the importance of professional guidance itself: patients tended to rate it higher than clinicians did, suggesting that people going through a taper want more hands-on support than they sometimes receive.
If your prescriber seems to approach discontinuation as a quick process, or if you feel you are not getting enough support, it is reasonable to ask for a more gradual schedule and a clear plan for check-ins during the taper. You are not being difficult. The research supports the idea that a personalized approach with regular monitoring leads to better outcomes. A phone call or brief appointment two weeks into a dose change can catch problems early before they snowball.
Timing matters, too. Starting a taper during a period of high stress, a major life transition, or seasonal depression risk is generally a bad idea. If your reason for stopping is side effects rather than feeling ready to be medication-free, your prescriber may suggest switching to a different medication first and then tapering bupropion once the new one is established, rather than leaving you without pharmacological support during the transition.
How Therapy Can Reduce the Risk of Relapse
One of the biggest concerns about stopping any antidepressant is whether depression will come back. The evidence on combining therapy with a medication taper is encouraging, though not perfectly straightforward. A systematic review found that at two years, people who received cognitive behavioral therapy alongside their taper had a substantially lower risk of relapse compared to those who tapered with standard clinical management alone.8PubMed Central. Managing Antidepressant Discontinuation: A Systematic Review The therapy group’s relapse rates ranged from about 15 to 25 percent, while the clinical-management group ranged from 35 to 80 percent.
A Cochrane review looking at the same question found more modest results, suggesting that discontinuation combined with psychological intervention may result in little difference in relapse compared to simply continuing antidepressants, though the certainty of the evidence was rated as low.9Cochrane Database of Systematic Reviews. Approaches to limiting long-term antidepressant use in depressive and anxiety disorders The two findings are not necessarily contradictory; they reflect different comparisons. The first compares therapy-plus-taper to taper-alone. The second compares therapy-plus-taper to staying on the medication altogether. The upshot: therapy during a taper clearly helps compared to tapering without therapy, but it may not fully replace the protection that staying on medication offers. If you have had multiple depressive episodes, talking to a therapist before and during your taper is one of the most evidence-backed things you can do.
Drug Interactions During the Tapering Period
Bupropion is metabolized through multiple pathways in the liver, with no single pathway dominating. This means that if one metabolic route is slowed by another medication, others can pick up the slack, and in practice few clinically significant drug interactions have been observed with bupropion.10SpringerLink / Drugs. Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation However, the potential for interactions still exists, particularly with drugs that affect certain liver enzymes.
Bupropion is a strong inhibitor of the CYP2D6 enzyme, which means that while you are on it, other drugs metabolized by that enzyme may be present at higher levels in your body than they otherwise would be. As you taper off bupropion and its inhibitory effect wanes, the blood levels of those other medications may drop. If you take another psychiatric medication, a beta-blocker, or certain other drugs metabolized through CYP2D6, your prescriber should be aware of the timing of your taper so they can adjust doses if needed. This is an easy thing to overlook, so mention every other medication you take when discussing your taper plan.
Alcohol is worth a specific mention. Bupropion lowers the seizure threshold, and alcohol does the same. During a taper, when your body is adjusting, heavy drinking increases risk. If alcohol is part of your routine, being honest with your prescriber about it helps them make better decisions about your tapering speed and monitoring schedule.
Weight and Appetite Changes After Stopping
Bupropion is one of the few antidepressants associated with weight neutrality or even modest weight loss, which is part of its appeal for many people. A reasonable concern when stopping is whether weight gain will follow. The honest answer is that it can, but the picture is more nuanced than a simple rebound effect.
When bupropion is used alongside behavioral interventions for smoking cessation, studies have tracked weight changes carefully. In one trial, women who quit smoking while taking bupropion gained about 5 kg over three months, which was comparable to the weight gain in placebo groups.11PubMed Central. Bupropion and Cognitive Behavioral Therapy for Weight-Concerned Women Smokers That trial measured weight during treatment rather than after stopping bupropion, but it illustrates an important broader point: much of the weight change attributed to bupropion discontinuation may actually reflect the removal of a mild appetite-suppressing effect rather than a direct withdrawal-driven metabolic shift. If bupropion was keeping your appetite slightly in check, stopping it may bring your appetite back to its natural baseline. That is not the same as the medication causing weight gain, but the end result on the scale can feel the same.
If weight management is a significant concern for you, discussing it with your prescriber before the taper is worthwhile. Small adjustments to diet and exercise during the transition period can offset the appetite shift for many people. This is especially true if bupropion was originally prescribed partly for its weight-neutral profile.
What Real-World Experiences Add to the Clinical Picture
Clinical trials are designed to isolate the effect of stopping a medication under controlled conditions, but the lived experience of tapering is messier. A large qualitative study analyzing over 3,200 user reviews of antidepressants found that people’s experiences were characterized by trial-and-error experimentation, uncertainty about what was causing their symptoms, and unforeseen withdrawal challenges.12Qualitative Social Work. The micro-to-macro realities of antidepressant taking: Users’ experiences in the context of contested science and industry promotion That study focused on serotonergic antidepressants, but the themes resonate across medication types: people often feel underprepared for what discontinuation actually feels like, and the gap between clinical trial data and daily life can be jarring.
Online communities for people stopping antidepressants are full of detailed personal accounts that do not neatly match the symptom checklists in medical literature. Some people report emotional blunting lifting within days of stopping bupropion and feeling more like themselves. Others describe weeks of low motivation and brain fog that they were not warned about. Neither experience invalidates the other; individual variation in metabolism, dosing history, and baseline neurobiology creates a wide range of outcomes. The evidence is clear that withdrawal syndromes can occur even with careful tapering, but the specific texture of what a person feels is still poorly captured by standardized symptom scales.
What the real-world accounts consistently reinforce is the value of being informed ahead of time. People who knew to expect some discomfort, who had a timeline in mind for when symptoms should fade, and who had a plan for contacting their prescriber if things got worse generally described the process as manageable. People who were told “just stop taking it” or given no guidance at all were more likely to describe the experience as frightening or overwhelming, even if their objective symptom severity was similar. Preparation does not change the pharmacology, but it changes how you experience the transition.
When Stopping Might Not Be the Right Move
Not everyone who considers stopping bupropion should actually stop. If you have had three or more depressive episodes, current guidelines generally recommend long-term maintenance treatment because the risk of recurrence is high. If your depression was severe, if it took a long time to find a medication that worked, or if you are currently under significant life stress, the calculus shifts toward staying on treatment for now and revisiting the question later.
Wanting to stop because of side effects is a different situation from wanting to stop because you feel better. If the side effects are the problem, a dose reduction or a switch to a different medication may solve the issue without exposing you to the risk of untreated depression. If you feel you no longer need the medication because your life circumstances have improved, that is a conversation worth having with your prescriber, but keep in mind that feeling better is often evidence that the medication is working rather than evidence that it is no longer necessary.
Pregnancy planning is another common reason people consider stopping bupropion. The risk-benefit conversation in that context is specific and individualized. Bupropion is not the riskiest antidepressant during pregnancy, but it is not without concerns, and untreated depression during pregnancy carries its own serious risks. This is a decision that belongs to you, your prescriber, and ideally an obstetrician working together, not one to make based on general advice.